Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
Robson A.S. Santos, Walkyria Oliveira Sampaio, Andréia Carvalho Alzamora, et al.
Physiological Reviews (2017) Vol. 98, Iss. 1, pp. 505-553
Open Access | Times Cited: 982

Showing 1-25 of 982 citing articles:

Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
Hua Su, Ming Yang, Cheng Wan, et al.
Kidney International (2020) Vol. 98, Iss. 1, pp. 219-227
Open Access | Times Cited: 1711
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
Paolo Verdecchia, Claudio Cavallini, Antonio Spanevello, et al.
European Journal of Internal Medicine (2020) Vol. 76, pp. 14-20
Open Access | Times Cited: 1217
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
Wentao Ni, Xiuwen Yang, Deqing Yang, et al.
Critical Care (2020) Vol. 24, Iss. 1
Open Access | Times Cited: 1121
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Carsten Tschöpe, Enrico Ammirati, Biykem Bozkurt, et al.
Nature Reviews Cardiology (2020) Vol. 18, Iss. 3, pp. 169-193
Open Access | Times Cited: 879
Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19
Hao Cheng, Yan Wang, Gui‐Qiang Wang
Journal of Medical Virology (2020) Vol. 92, Iss. 7, pp. 726-730
Open Access | Times Cited: 533
Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Junyi Guo, Zheng Huang, Li Lin, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 7
Open Access | Times Cited: 477
COVID-19 cytokine storm: The anger of inflammation
Mehdi Mahmudpour, Jamshid Roozbeh, Mohsen Keshavarz, et al.
Cytokine (2020) Vol. 133, pp. 155151-155151
Open Access | Times Cited: 452
COVID-19–related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids
Michael C. Peters, Satria P. Sajuthi, Peter DeFord, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 202, Iss. 1, pp. 83-90
Open Access | Times Cited: 444
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19
Hisashi Kai, Mamiko Kai
Hypertension Research (2020) Vol. 43, Iss. 7, pp. 648-654
Open Access | Times Cited: 431
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies
Gong Feng, Kenneth I. Zheng, Qinqin Yan, et al.
Journal of Clinical and Translational Hepatology (2020) Vol. 8, Iss. 1, pp. 1-7
Open Access | Times Cited: 409
Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis
Xinhui Wang, Xuexian Fang, Zhaoxian Cai, et al.
Research (2020) Vol. 2020
Open Access | Times Cited: 385
Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19
Reinhold Kreutz, Engi Algharably, Michel Azizi, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 10, pp. 1688-1699
Open Access | Times Cited: 355
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
Lauren B. Arendse, A.H. Jan Danser, Marko Poglitsch, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 4, pp. 539-570
Open Access | Times Cited: 315
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran, et al.
Biochimie (2020) Vol. 179, pp. 85-100
Open Access | Times Cited: 310
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension
Guang Yang, Zihu Tan, Ling Zhou, et al.
Hypertension (2020) Vol. 76, Iss. 1, pp. 51-58
Open Access | Times Cited: 305
The renin-angiotensin system: going beyond the classical paradigms
Robson A.S. Santos, Gavin Y. Oudit, Thiago Verano‐Braga, et al.
AJP Heart and Circulatory Physiology (2019) Vol. 316, Iss. 5, pp. H958-H970
Open Access | Times Cited: 283
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
Matthias P. Nägele, Bernhard J. Haubner, Felix C. Tanner, et al.
Atherosclerosis (2020) Vol. 314, pp. 58-62
Open Access | Times Cited: 274
Prognostic value of NT-proBNP in patients with severe COVID-19
Lei Gao, Dan Jiang, Xuesong Wen, et al.
Respiratory Research (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 271
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
Francesca Salamanna, Melania Maglio, Maria Paola Landini, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 256
Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19
Rakhee K. Ramakrishnan, Tarek Kashour, Qutayba Hamid, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 220
Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system
Changmeng Cui, Pengfei Xu, Gongying Li, et al.
Redox Biology (2019) Vol. 26, pp. 101295-101295
Open Access | Times Cited: 204
COVID-19 and thrombosis: From bench to bedside
Mohammad Ali, Sarah A. Spinler
Trends in Cardiovascular Medicine (2020) Vol. 31, Iss. 3, pp. 143-160
Open Access | Times Cited: 202
A hypothesis for pathobiology and treatment of COVID‐19: The centrality of ACE1/ACE2 imbalance
Krishna Sriram, Paul A. Insel
British Journal of Pharmacology (2020) Vol. 177, Iss. 21, pp. 4825-4844
Open Access | Times Cited: 189
Extrapulmonary complications of COVID‐19: A multisystem disease?
Kenneth I. Zheng, Gong Feng, Wen‐Yue Liu, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 1, pp. 323-335
Open Access | Times Cited: 187
Therapeutic potential of curcumin in diabetic complications
Negin Parsamanesh, Maryam Moossavi, Afsane Bahrami, et al.
Pharmacological Research (2018) Vol. 136, pp. 181-193
Closed Access | Times Cited: 185
Page 1 - Next Page

Scroll to top